Abstract
The intertwining of chemoinformatics with artificial intelligence (AI) has given a tremendous fillip to the field of drug discovery. With the rapid growth of chemical data from high throughput screening and combinatorial synthesis, AI has become an indispensable tool for drug designers to mine chemical information from large compound databases for developing drugs at a much faster rate as never before. The applications of AI have gone beyond bioactivity predictions and have shown promise in addressing diverse problems in drug discovery like de novo molecular design, synthesis prediction and biological image analysis. In this article, we provide an overview of all the algorithms under the umbrella of AI, enlist the tools/frameworks required for implementing these algorithms as well as present a compendium of web servers, databases and open-source platforms implicated in drug discovery, Quantitative Structure-Activity Relationship (QSAR), data mining, solvation free energy and molecular graph mining.
Keywords: Chemoinformatics, Drug discovery, Artificial intelligence, Machine learning, Deep learning, QSAR analysis, Generative models, Data/graph mining.
Current Topics in Medicinal Chemistry
Title:Intelligently Applying Artificial Intelligence in Chemoinformatics
Volume: 18 Issue: 20
Author(s): Sahil Sharma and Deepak Sharma*
Affiliation:
- Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667,India
Keywords: Chemoinformatics, Drug discovery, Artificial intelligence, Machine learning, Deep learning, QSAR analysis, Generative models, Data/graph mining.
Abstract: The intertwining of chemoinformatics with artificial intelligence (AI) has given a tremendous fillip to the field of drug discovery. With the rapid growth of chemical data from high throughput screening and combinatorial synthesis, AI has become an indispensable tool for drug designers to mine chemical information from large compound databases for developing drugs at a much faster rate as never before. The applications of AI have gone beyond bioactivity predictions and have shown promise in addressing diverse problems in drug discovery like de novo molecular design, synthesis prediction and biological image analysis. In this article, we provide an overview of all the algorithms under the umbrella of AI, enlist the tools/frameworks required for implementing these algorithms as well as present a compendium of web servers, databases and open-source platforms implicated in drug discovery, Quantitative Structure-Activity Relationship (QSAR), data mining, solvation free energy and molecular graph mining.
Export Options
About this article
Cite this article as:
Sharma Sahil and Sharma Deepak*, Intelligently Applying Artificial Intelligence in Chemoinformatics, Current Topics in Medicinal Chemistry 2018; 18 (20) . https://dx.doi.org/10.2174/1568026619666181120150938
DOI https://dx.doi.org/10.2174/1568026619666181120150938 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chronic Kidney Disease
The scope of the special thematic issue includes but not limited to the mechanism of chronic kidney disease (CKD), the treatment of renal fibrosis and early diagnosis of CKD and so on. We also welcome manuscripts from other scientific research area with respect to internal medicine. Cell death has been ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in Adenylation Domain Enzymology in Nonribosomal Peptide Biosynthesis
Current Organic Chemistry Patent Selections:
Recent Patents on Anti-Infective Drug Discovery DNA Vaccines.
Current Molecular Medicine The Extent of Delay in Diagnosis, Treatment and their Associated Factors among Tuberculosis Patients Attending Government Hospitals of Rishikesh, Uttarakhand: A Cross-Sectional Study
Recent Advances in Anti-Infective Drug Discovery Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies
Current Protein & Peptide Science Editorial [ Hot Topic: Drug-Resistant Tuberculosis - A Challenge in Chemotherapy (Guest Editor: Iwao Ojima) ]
Current Topics in Medicinal Chemistry Targeting IL-17 and IL-23 in Immune Mediated Renal Disease
Current Medicinal Chemistry Energy Provisioning and Inflammasome Activation: The Pivotal Role of AMPK in Sterile Inflammation and Associated Metabolic Disorders
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Graphical Abstracts
Letters in Drug Design & Discovery Drug Susceptibility Testing for Optimizing Tuberculosis Treatment
Current Pharmaceutical Design Synthesis of 2-Hydroxynaphthyl Pyrazolines Containing Isoniazid Moiety: A Potential Antitubercular Agent
Letters in Organic Chemistry Verapamil Regulates the Macrophage Immunity to <i>Mycobacterium tuberculosis</i> through NF-κB Signaling
Current Molecular Medicine Medicinal Chemistry Updates on Bacterial Efflux Pump Modulators
Current Medicinal Chemistry Vascular Endothelial Growth Factor (VEGF) in Pleural Effusions
Current Enzyme Inhibition Drug Resistance, Virus Fitness and HIV-1 Mutagenesis
Current Pharmaceutical Design Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2
Current Medicinal Chemistry Covid-19 Susceptibility and Severity Might be Modified by Vitamin D Status: Theoretical and Practical Considerations
Current Respiratory Medicine Reviews Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Biologically Active Agents
Current Medicinal Chemistry Adenosine and Adenosine Receptors in the Pathomechanism and Treatment of Respiratory Diseases
Current Medicinal Chemistry Leishmaniasis: History, Evolution of Treatment and the Need for New Drugs
Current Biotechnology